Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ETCompany ParticipantsJulie Dewey - Chief Investor Relations ...

Learn the 5 strategies that reduce diabetes-related amputation risk, from proper foot examinations and self-monitoring to ...

Discover the foot care oversights people with type 2 diabetes make and learn simple preventive strategies to protect ...

MolecuLight Corp. further strengthened its market position in June 2022 through a group purchasing agreement with Premier, ...

MED's second product, is being developed to provide safe, real-time optical readings of biomarkers for assessment of diabetic ...

The Cuban business conglomerate BioCubaFarma has entered into a biotechnological and pharmaceutical cooperation agreement ...

Microbion Phase 2 study shows favorable safety and early efficacy data, with 46.7% of patients treated achieving complete wound closure. A ...

See other news and announcements from the Amarillo area business community here, including a rooftop patio bar and upcoming ...

Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed studies describing the efficacy of the company's ...

Proven cold plasma therapy system for chronic wound treatment represents patient-first innovation. The Plasoma cold plasma system represents the kind of patient-first innovation our industry needs.” — ...

Musician has been frank about his ongoing health issues and recently revealed he came close to having his feet or toes ...